Buy Amar Remedies: Bonanza Portfolio Limited

Avinash Gupta, Assistant Vice President Research Equity, Bonanza Portfolio Limited in an interview with ET Now talks about Amar Remedies.

One word on the top midcap ideas that you are giving out to your clients right now at Bonanza? For people who have 6-month horizon, are there any good midcap stocks which would give 50% to 100% return over the next 6 months to over a year’s time?

We have recommended Amar Remedies to our clients which is in the FMCG space and has been showing good growth and is available at a reasonable valuation. This is available at about 7-8 PE ratio which is fairly attractive for this size of the company.